| |
|
|
| Name: |
Affinity Asset Advisors LLC |
| City: |
Bridgehampton |
| State: |
NY |
| Zip: |
11932 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
12 |
|
View All Holdings |
Currently
Viewing:
New Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
IMGN |
Immunogen Inc |
1 |
New |
$31.23 |
$41,647,000 |
1,404,608 |
8.79% |
41,647,000 |
1,404,608 |
0.636 |
Drug Manufacturers - ... |
|
|
CMPS |
Compass Pathways Plc |
28 |
New |
$0.00 |
$4,813,000 |
550,000 |
1.02% |
4,813,000 |
550,000 |
1.58 |
N/A |
|
|
RLAY |
Relay Therapeutics, Inc. |
35 |
New |
$6.42 |
$3,303,000 |
300,000 |
0.7% |
3,303,000 |
300,000 |
0.222 |
N/A |
|
|
CGEM |
Cullinan Oncology Ord Shs |
38 |
New |
$0.00 |
$3,057,000 |
300,000 |
0.64% |
3,057,000 |
300,000 |
0.689 |
N/A |
|
|
ARGX |
Argenx Se |
40 |
New |
$374.63 |
$2,853,000 |
7,500 |
0.6% |
2,853,000 |
7,500 |
0.016 |
N/A |
|
|
EYPT |
EyePoint Pharmaceuticals Inc |
42 |
New |
$0.44 |
$2,540,000 |
109,900 |
0.54% |
2,540,000 |
109,900 |
0.077 |
Biotechnology |
|
|
PEN |
Penumbra Inc |
46 |
New |
$212.28 |
$1,887,000 |
7,500 |
0.4% |
1,887,000 |
7,500 |
0.021 |
N/A |
|
|
NBIX |
Neurocrine Biosciences Inc |
53 |
New |
$136.70 |
$1,318,000 |
10,000 |
0.28% |
1,318,000 |
10,000 |
0.011 |
Biotechnology |
|
|
NARI |
Inari Medical, Inc. |
54 |
New |
$0.00 |
$1,298,000 |
20,000 |
0.27% |
1,298,000 |
20,000 |
0.039 |
N/A |
|
|
ALLO |
Allogene Therapeutics, Inc. |
55 |
New |
$0.00 |
$1,284,000 |
400,000 |
0.27% |
1,284,000 |
400,000 |
0.285 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
57 |
New |
$13.90 |
$1,089,000 |
50,000 |
0.23% |
1,089,000 |
50,000 |
0.11 |
N/A |
|
|
FULC |
Fulcrum Therapeutics, Inc. |
60 |
New |
$0.00 |
$844,000 |
125,000 |
0.18% |
844,000 |
125,000 |
0.198 |
N/A |
|
